How to Help Your Patients Find Isosorbide in Stock: A Provider's Guide

The 2026 isosorbide supply shortage has turned a routine refill into a stressful medication hunt for many angina patients. As a prescriber, you're likely fielding calls from patients who can't get their isosorbide mononitrate or dinitrate filled — or worse, patients who are running dangerously low and don't know where to turn.

This guide is designed for cardiologists, internists, and primary care providers who want practical, actionable tools to help their patients find isosorbide in stock — and to prevent dangerous gaps in heart medication therapy.

Why Patients Are Struggling to Fill Isosorbide in 2026

The root cause: all brand-name isosorbide mononitrate products have been discontinued, leaving the market entirely to generic manufacturers. With fewer suppliers, any production disruption — manufacturing delay, API sourcing issue, or regulatory hold — causes visible pharmacy-level shortages.

The 10 mg and 20 mg immediate-release tablets have been most affected. Extended-release (30, 60, 120 mg) formulations often have better availability because they come from different production runs. One practical short-term strategy: ask patients if their insurance covers the extended-release formulation.

Prescribing Strategies That Improve Fillability

Small changes to how you write the prescription can make a big difference:

• Prescribe "dispense as written" cautiously. For isosorbide, all formulations are generic — "dispense as written" isn't applicable. However, specifying a specific generic manufacturer by name (if you know which one is in supply) can help pharmacists source it from the right wholesaler.
• Allow generic substitution across formulations. Where clinically appropriate, write a note in the prescription authorizing the pharmacist to fill with extended-release if immediate-release is unavailable (e.g., "may substitute ISMN ER 30 mg QD if IR unavailable").
• Prescribe 90-day supplies. When a patient does find isosorbide in stock, a 90-day supply reduces future refill crises. Most insurance plans now allow 90-day fills for maintenance medications.
• Consider mail-order pharmacy. Mail-order pharmacies often have supply agreements with different manufacturers than retail pharmacies. For long-term maintenance therapy, mail-order is often the more reliable channel.

How to Direct Patients to Find Isosorbide in Stock

Most patients don't know how to systematically search for medication availability. Here's the framework to share with them:

1. Call your regular pharmacy and ask specifically about the strength and form. If they don't have it, ask when the next shipment is expected.
2. Ask the pharmacist to check nearby locations of the same chain.
3. Try Costco, grocery store pharmacies, and independent pharmacies — these often source from different wholesalers than major chains.
4. Use medfinder, which calls pharmacies near the patient and returns a list of which ones can fill the prescription — eliminating the manual calling process.

Referring Patients to medfinder

medfinder is a patient service that calls pharmacies on behalf of patients to find which ones have their specific prescription in stock. The patient enters their medication, dosage, and zip code — medfinder calls nearby pharmacies and texts results. For older patients with limited mobility or difficulty making multiple calls, this service can be especially valuable. Providers can learn more at medfinder.com/providers.

Setting Up a Practice Protocol for Shortage Management

Practices that create a shortage response protocol handle these situations more efficiently. Consider establishing:

• A list of pre-approved therapeutic substitutes for isosorbide (with nursing/MA permission to initiate the substitution protocol with provider sign-off)
• A standing message template for staff to send patients who call about isosorbide shortage
• A pharmacy partner list — identify 2–3 pharmacies that reliably carry isosorbide and keep contact information at the front desk
• Clear patient instructions: "If your pharmacy is out, call our office before stopping the medication"

When to Escalate: Identifying High-Risk Patients

Not all isosorbide patients carry the same risk during a shortage. Prioritize these patients for proactive outreach:

• Patients with severe or frequently symptomatic stable angina
• Patients where isosorbide is the only antianginal (no beta-blocker or CCB on board)
• Patients on BiDil (isosorbide dinitrate + hydralazine) for heart failure — this is an FDA-approved combination for a specific indication in African Americans and carries separate clinical considerations
• Elderly patients who may have difficulty navigating pharmacy calls on their own

Bottom Line for Providers

The isosorbide shortage is manageable with the right strategies. Proactive identification of at-risk patients, smart prescribing practices, and directing patients to tools like medfinder will go a long way toward preventing dangerous medication gaps. For deeper clinical guidance, see our provider-focused shortage update for therapeutic substitution pathways and clinical framework.